Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tissue Engineering | 49 | 2020 | 608 | 5.820 |
Why?
|
Stem Cells | 29 | 2018 | 292 | 4.460 |
Why?
|
Tissue Scaffolds | 34 | 2020 | 386 | 4.210 |
Why?
|
Bioengineering | 13 | 2017 | 67 | 3.570 |
Why?
|
Cell Differentiation | 23 | 2018 | 436 | 3.430 |
Why?
|
Extracellular Matrix | 25 | 2020 | 226 | 2.850 |
Why?
|
Endothelial Cells | 18 | 2016 | 179 | 2.720 |
Why?
|
Liver | 17 | 2018 | 464 | 2.690 |
Why?
|
Neovascularization, Physiologic | 10 | 2016 | 106 | 2.600 |
Why?
|
Organoids | 8 | 2018 | 68 | 2.500 |
Why?
|
Amniotic Fluid | 11 | 2013 | 84 | 2.500 |
Why?
|
Animals | 80 | 2019 | 7297 | 2.360 |
Why?
|
Vascular Endothelial Growth Factor A | 18 | 2016 | 103 | 2.310 |
Why?
|
Cell Proliferation | 26 | 2018 | 573 | 2.280 |
Why?
|
Endothelium, Corneal | 5 | 2015 | 22 | 2.280 |
Why?
|
Regenerative Medicine | 11 | 2018 | 187 | 2.170 |
Why?
|
Amnion | 5 | 2019 | 36 | 2.010 |
Why?
|
Stem Cell Transplantation | 11 | 2017 | 203 | 1.910 |
Why?
|
Epithelial Cells | 6 | 2017 | 138 | 1.740 |
Why?
|
Trans-Activators | 4 | 2017 | 47 | 1.710 |
Why?
|
Homeodomain Proteins | 4 | 2017 | 50 | 1.700 |
Why?
|
Pancreas | 7 | 2020 | 79 | 1.670 |
Why?
|
Mice | 34 | 2018 | 2368 | 1.660 |
Why?
|
Muscle, Skeletal | 8 | 2018 | 494 | 1.520 |
Why?
|
Cells, Cultured | 33 | 2018 | 799 | 1.500 |
Why?
|
Blood Vessel Prosthesis | 9 | 2014 | 78 | 1.420 |
Why?
|
Humans | 94 | 2020 | 29093 | 1.360 |
Why?
|
Models, Biological | 4 | 2017 | 373 | 1.240 |
Why?
|
Endothelium, Vascular | 10 | 2014 | 145 | 1.240 |
Why?
|
Hydrogels | 8 | 2019 | 103 | 1.190 |
Why?
|
Biocompatible Materials | 12 | 2018 | 210 | 1.160 |
Why?
|
Regeneration | 13 | 2016 | 167 | 1.160 |
Why?
|
Organ Transplantation | 6 | 2014 | 65 | 1.090 |
Why?
|
Islets of Langerhans | 4 | 2020 | 74 | 1.080 |
Why?
|
Cell Culture Techniques | 14 | 2018 | 165 | 1.020 |
Why?
|
Bioreactors | 11 | 2017 | 59 | 0.910 |
Why?
|
Myoblasts, Skeletal | 2 | 2016 | 16 | 0.900 |
Why?
|
Kidney | 8 | 2017 | 485 | 0.900 |
Why?
|
Insulin | 2 | 2016 | 346 | 0.880 |
Why?
|
Insulin-Secreting Cells | 4 | 2020 | 53 | 0.850 |
Why?
|
Tissue Array Analysis | 3 | 2017 | 34 | 0.840 |
Why?
|
Collagen | 8 | 2017 | 217 | 0.810 |
Why?
|
Neovascularization, Pathologic | 6 | 2005 | 81 | 0.810 |
Why?
|
Rats | 17 | 2017 | 1604 | 0.800 |
Why?
|
Bioprosthesis | 4 | 2014 | 55 | 0.790 |
Why?
|
Cell Movement | 6 | 2013 | 161 | 0.790 |
Why?
|
Neuropilin-1 | 8 | 2008 | 11 | 0.780 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2017 | 104 | 0.780 |
Why?
|
Endothelial Growth Factors | 5 | 2002 | 12 | 0.760 |
Why?
|
Blood Vessels | 4 | 2014 | 47 | 0.750 |
Why?
|
Cell Separation | 4 | 2015 | 86 | 0.720 |
Why?
|
Wound Healing | 4 | 2019 | 182 | 0.710 |
Why?
|
Organogenesis | 3 | 2018 | 15 | 0.710 |
Why?
|
Lymphokines | 4 | 2002 | 10 | 0.710 |
Why?
|
Fluorouracil | 3 | 2017 | 73 | 0.700 |
Why?
|
Culture Media | 4 | 2016 | 39 | 0.700 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2016 | 9 | 0.700 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2016 | 40 | 0.690 |
Why?
|
Colorectal Neoplasms | 2 | 2019 | 208 | 0.670 |
Why?
|
Immunohistochemistry | 12 | 2017 | 519 | 0.660 |
Why?
|
Fluorescent Dyes | 2 | 2018 | 45 | 0.660 |
Why?
|
Muscle Development | 2 | 2018 | 45 | 0.640 |
Why?
|
Corneal Transplantation | 2 | 2015 | 13 | 0.640 |
Why?
|
Bile Ducts | 1 | 2018 | 18 | 0.630 |
Why?
|
Intercellular Signaling Peptides and Proteins | 5 | 2017 | 100 | 0.630 |
Why?
|
Mucous Membrane | 1 | 2017 | 20 | 0.630 |
Why?
|
Mesenchymal Stem Cells | 5 | 2017 | 161 | 0.620 |
Why?
|
Rheology | 3 | 2016 | 28 | 0.620 |
Why?
|
Activins | 1 | 2017 | 3 | 0.620 |
Why?
|
Niacinamide | 1 | 2017 | 8 | 0.620 |
Why?
|
Hepatocytes | 8 | 2018 | 74 | 0.610 |
Why?
|
Ethanol | 3 | 2015 | 185 | 0.610 |
Why?
|
Heparin | 2 | 2016 | 75 | 0.610 |
Why?
|
Liver Neoplasms | 2 | 2017 | 162 | 0.600 |
Why?
|
Liver Transplantation | 6 | 2014 | 111 | 0.590 |
Why?
|
Ferrets | 6 | 2018 | 19 | 0.580 |
Why?
|
Myocytes, Cardiac | 3 | 2017 | 87 | 0.580 |
Why?
|
Cell Cycle | 1 | 2016 | 69 | 0.580 |
Why?
|
Mouth Mucosa | 2 | 2016 | 29 | 0.580 |
Why?
|
Cell Transplantation | 2 | 2014 | 63 | 0.580 |
Why?
|
Occupational Exposure | 2 | 2016 | 224 | 0.570 |
Why?
|
Mice, Nude | 7 | 2017 | 276 | 0.570 |
Why?
|
Epidermal Growth Factor | 1 | 2016 | 21 | 0.570 |
Why?
|
Swine | 9 | 2019 | 201 | 0.560 |
Why?
|
Cells, Immobilized | 1 | 2016 | 23 | 0.560 |
Why?
|
Wounds and Injuries | 2 | 2016 | 250 | 0.550 |
Why?
|
Cytokines | 2 | 2017 | 243 | 0.550 |
Why?
|
Cross-Linking Reagents | 2 | 2014 | 16 | 0.540 |
Why?
|
Limbus Corneae | 1 | 2015 | 7 | 0.540 |
Why?
|
Peptides | 1 | 2016 | 118 | 0.540 |
Why?
|
Compartment Syndromes | 2 | 2014 | 38 | 0.530 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 199 | 0.520 |
Why?
|
Gelatin | 2 | 2016 | 27 | 0.520 |
Why?
|
Apoptosis | 2 | 2016 | 337 | 0.510 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 481 | 0.490 |
Why?
|
Postural Balance | 1 | 2016 | 160 | 0.480 |
Why?
|
Bioartificial Organs | 3 | 2014 | 25 | 0.480 |
Why?
|
Fetal Stem Cells | 2 | 2010 | 10 | 0.480 |
Why?
|
Cell Line | 5 | 2018 | 449 | 0.470 |
Why?
|
Nicotine | 1 | 2016 | 157 | 0.470 |
Why?
|
Skin | 3 | 2012 | 203 | 0.470 |
Why?
|
Extracellular Matrix Proteins | 2 | 2013 | 40 | 0.460 |
Why?
|
Pesticides | 1 | 2016 | 189 | 0.460 |
Why?
|
Disease Models, Animal | 7 | 2019 | 980 | 0.450 |
Why?
|
Hep G2 Cells | 4 | 2016 | 23 | 0.450 |
Why?
|
Elastic Modulus | 1 | 2012 | 24 | 0.450 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 235 | 0.450 |
Why?
|
Transients and Migrants | 1 | 2016 | 281 | 0.440 |
Why?
|
Myocardium | 2 | 2015 | 170 | 0.440 |
Why?
|
Muscles | 1 | 2012 | 53 | 0.430 |
Why?
|
Cell Survival | 9 | 2019 | 272 | 0.430 |
Why?
|
Kidney Transplantation | 6 | 2014 | 348 | 0.420 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 680 | 0.420 |
Why?
|
Gastrointestinal Diseases | 1 | 2012 | 38 | 0.410 |
Why?
|
Osteogenesis | 3 | 2010 | 75 | 0.400 |
Why?
|
General Surgery | 1 | 2012 | 81 | 0.400 |
Why?
|
Neoplasms | 2 | 2016 | 610 | 0.390 |
Why?
|
Corneal Stroma | 1 | 2010 | 6 | 0.380 |
Why?
|
Aging | 3 | 2017 | 881 | 0.380 |
Why?
|
Hyaluronic Acid | 4 | 2018 | 45 | 0.380 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 6 | 2015 | 20 | 0.370 |
Why?
|
Organ Culture Techniques | 2 | 2013 | 38 | 0.370 |
Why?
|
Coculture Techniques | 4 | 2015 | 74 | 0.360 |
Why?
|
Tissue Donors | 2 | 2010 | 167 | 0.360 |
Why?
|
Hispanic Americans | 1 | 2016 | 904 | 0.350 |
Why?
|
Calcinosis | 1 | 2010 | 143 | 0.340 |
Why?
|
Cell Fractionation | 1 | 2009 | 7 | 0.340 |
Why?
|
Cell-Free System | 1 | 2009 | 15 | 0.340 |
Why?
|
Ferric Compounds | 1 | 2008 | 14 | 0.340 |
Why?
|
Angiogenesis Inhibitors | 2 | 2007 | 34 | 0.340 |
Why?
|
Cell Lineage | 3 | 2018 | 67 | 0.330 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2005 | 17 | 0.330 |
Why?
|
Materials Testing | 6 | 2015 | 84 | 0.330 |
Why?
|
Female | 22 | 2017 | 18164 | 0.330 |
Why?
|
Endostatins | 2 | 2007 | 3 | 0.320 |
Why?
|
Nerve Tissue Proteins | 3 | 2013 | 118 | 0.320 |
Why?
|
Sus scrofa | 5 | 2015 | 44 | 0.320 |
Why?
|
Male | 21 | 2017 | 17807 | 0.320 |
Why?
|
Rabbits | 4 | 2017 | 185 | 0.300 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2019 | 50 | 0.300 |
Why?
|
Bone Marrow Cells | 1 | 2007 | 114 | 0.300 |
Why?
|
Central Nervous System Depressants | 1 | 2007 | 63 | 0.300 |
Why?
|
Carotid Arteries | 3 | 2012 | 97 | 0.300 |
Why?
|
Urinary Bladder | 4 | 2012 | 164 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 89 | 0.290 |
Why?
|
Angiogenesis Modulating Agents | 1 | 2006 | 1 | 0.290 |
Why?
|
Growth Substances | 1 | 2006 | 7 | 0.290 |
Why?
|
Liver Regeneration | 3 | 2017 | 23 | 0.290 |
Why?
|
Urethra | 3 | 2012 | 100 | 0.290 |
Why?
|
Perfusion | 3 | 2016 | 64 | 0.290 |
Why?
|
Microscopy, Fluorescence | 4 | 2014 | 81 | 0.280 |
Why?
|
Myocardial Infarction | 1 | 2010 | 412 | 0.280 |
Why?
|
Heart | 4 | 2017 | 161 | 0.280 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 63 | 0.270 |
Why?
|
Optical Phenomena | 2 | 2015 | 5 | 0.270 |
Why?
|
Neuroblastoma | 1 | 2005 | 32 | 0.270 |
Why?
|
Gold | 1 | 2005 | 15 | 0.270 |
Why?
|
Rats, Inbred Lew | 5 | 2017 | 116 | 0.260 |
Why?
|
Phenotype | 2 | 2017 | 629 | 0.260 |
Why?
|
Collagen Type IV | 2 | 2016 | 8 | 0.260 |
Why?
|
Pressure | 3 | 2013 | 54 | 0.250 |
Why?
|
Blotting, Western | 4 | 2016 | 281 | 0.240 |
Why?
|
Rats, Sprague-Dawley | 5 | 2016 | 747 | 0.230 |
Why?
|
Hemodynamics | 2 | 2015 | 148 | 0.230 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 546 | 0.230 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 248 | 0.230 |
Why?
|
Stress, Mechanical | 4 | 2017 | 90 | 0.230 |
Why?
|
Fibronectins | 2 | 2013 | 34 | 0.230 |
Why?
|
Leukemia, Myeloid | 1 | 2002 | 24 | 0.230 |
Why?
|
Fiber Optic Technology | 2 | 2013 | 14 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 1218 | 0.220 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2012 | 68 | 0.220 |
Why?
|
Vascular Endothelial Growth Factors | 4 | 2002 | 12 | 0.220 |
Why?
|
Gene Expression | 3 | 2013 | 332 | 0.210 |
Why?
|
Receptors, Mitogen | 1 | 2002 | 2 | 0.210 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 2 | 0.210 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 18 | 0.210 |
Why?
|
Immune Tolerance | 3 | 2014 | 67 | 0.210 |
Why?
|
Neoplasm Proteins | 1 | 2002 | 141 | 0.210 |
Why?
|
Gastrointestinal Tract | 2 | 2012 | 29 | 0.200 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 72 | 0.200 |
Why?
|
Models, Animal | 4 | 2012 | 160 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 6 | 2010 | 22 | 0.200 |
Why?
|
Phosphorylation | 5 | 2009 | 225 | 0.200 |
Why?
|
Intestines | 2 | 2012 | 54 | 0.200 |
Why?
|
Mice, Inbred BALB C | 2 | 2014 | 160 | 0.200 |
Why?
|
Mice, SCID | 3 | 2008 | 71 | 0.200 |
Why?
|
Mice, Transgenic | 2 | 2016 | 249 | 0.200 |
Why?
|
Time Factors | 6 | 2016 | 2001 | 0.190 |
Why?
|
Flow Cytometry | 3 | 2011 | 171 | 0.190 |
Why?
|
Pancreatic Neoplasms | 1 | 2002 | 131 | 0.190 |
Why?
|
Myoblasts | 2 | 2012 | 38 | 0.190 |
Why?
|
Transfection | 4 | 2005 | 192 | 0.180 |
Why?
|
Urinary Incontinence, Stress | 2 | 2012 | 64 | 0.180 |
Why?
|
HCT116 Cells | 2 | 2017 | 11 | 0.180 |
Why?
|
Cystitis | 2 | 2010 | 8 | 0.180 |
Why?
|
Immunosuppression | 4 | 2013 | 80 | 0.180 |
Why?
|
Adult | 10 | 2016 | 8420 | 0.180 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2017 | 68 | 0.180 |
Why?
|
Calcium | 3 | 2017 | 296 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 152 | 0.170 |
Why?
|
Cell Adhesion | 4 | 2013 | 103 | 0.170 |
Why?
|
Signal Transduction | 3 | 2017 | 666 | 0.170 |
Why?
|
Collagen Type I | 1 | 2018 | 39 | 0.170 |
Why?
|
Kidney Failure, Chronic | 2 | 2014 | 518 | 0.160 |
Why?
|
Adenoviridae | 2 | 2012 | 61 | 0.160 |
Why?
|
Myogenic Regulatory Factor 5 | 1 | 2018 | 7 | 0.160 |
Why?
|
Transforming Growth Factor alpha | 1 | 2018 | 4 | 0.160 |
Why?
|
Tumor Cells, Cultured | 4 | 2016 | 158 | 0.160 |
Why?
|
Genes, Immediate-Early | 1 | 2017 | 2 | 0.160 |
Why?
|
Wnt Proteins | 1 | 2018 | 18 | 0.160 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2011 | 74 | 0.160 |
Why?
|
Fetal Blood | 1 | 2018 | 35 | 0.160 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 16 | 0.150 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 641 | 0.150 |
Why?
|
Antigens, Differentiation | 1 | 2017 | 21 | 0.150 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 711 | 0.150 |
Why?
|
Hematopoietic Stem Cells | 1 | 2018 | 95 | 0.150 |
Why?
|
Biosensing Techniques | 1 | 2017 | 20 | 0.150 |
Why?
|
Cattle | 4 | 2011 | 100 | 0.150 |
Why?
|
Tissue Culture Techniques | 2 | 2017 | 40 | 0.150 |
Why?
|
Gluconates | 1 | 2016 | 4 | 0.150 |
Why?
|
Ouabain | 1 | 2016 | 5 | 0.150 |
Why?
|
Hyperbaric Oxygenation | 1 | 2017 | 5 | 0.150 |
Why?
|
PAX7 Transcription Factor | 1 | 2016 | 8 | 0.150 |
Why?
|
Lung | 2 | 2017 | 233 | 0.150 |
Why?
|
Splenomegaly | 1 | 2016 | 6 | 0.150 |
Why?
|
Mice, Inbred ICR | 3 | 2016 | 14 | 0.150 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 9 | 0.150 |
Why?
|
Potassium | 1 | 2016 | 37 | 0.150 |
Why?
|
Cosmic Radiation | 1 | 2016 | 13 | 0.150 |
Why?
|
Liver, Artificial | 1 | 2016 | 5 | 0.150 |
Why?
|
Membrane Potentials | 1 | 2016 | 80 | 0.150 |
Why?
|
Dogs | 2 | 2014 | 117 | 0.150 |
Why?
|
Renal Insufficiency | 1 | 2017 | 53 | 0.140 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 13 | 0.140 |
Why?
|
Developmental Biology | 2 | 2018 | 7 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2016 | 67 | 0.140 |
Why?
|
Transduction, Genetic | 1 | 2016 | 42 | 0.140 |
Why?
|
Dental Pulp | 1 | 2016 | 1 | 0.140 |
Why?
|
Polyesters | 3 | 2016 | 72 | 0.140 |
Why?
|
Cadherins | 1 | 2016 | 24 | 0.140 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 58 | 0.140 |
Why?
|
Toxicity Tests | 1 | 2015 | 11 | 0.140 |
Why?
|
Optical Fibers | 1 | 2015 | 4 | 0.140 |
Why?
|
Umbilical Veins | 3 | 2005 | 12 | 0.130 |
Why?
|
Microvessels | 1 | 2015 | 23 | 0.130 |
Why?
|
Transplantation, Heterologous | 2 | 2008 | 121 | 0.130 |
Why?
|
Surface Properties | 2 | 2012 | 32 | 0.130 |
Why?
|
Case-Control Studies | 2 | 2016 | 859 | 0.130 |
Why?
|
Recovery of Function | 2 | 2014 | 190 | 0.130 |
Why?
|
Kidney Glomerulus | 1 | 2015 | 30 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2016 | 116 | 0.130 |
Why?
|
Neoplasm Transplantation | 2 | 2005 | 76 | 0.130 |
Why?
|
Middle Aged | 6 | 2016 | 10829 | 0.130 |
Why?
|
Jugular Veins | 2 | 2012 | 26 | 0.130 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2012 | 45 | 0.130 |
Why?
|
Transplants | 2 | 2014 | 22 | 0.130 |
Why?
|
Coated Materials, Biocompatible | 2 | 2013 | 17 | 0.130 |
Why?
|
Desmin | 2 | 2011 | 12 | 0.130 |
Why?
|
Mullerian Ducts | 1 | 2014 | 3 | 0.120 |
Why?
|
Ossification, Heterotopic | 1 | 2014 | 14 | 0.120 |
Why?
|
Pilot Projects | 3 | 2014 | 469 | 0.120 |
Why?
|
Graft Rejection | 2 | 2014 | 149 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2014 | 298 | 0.120 |
Why?
|
Congenital Abnormalities | 1 | 2014 | 10 | 0.120 |
Why?
|
Transplantation Immunology | 2 | 2010 | 27 | 0.120 |
Why?
|
Equipment Design | 4 | 2017 | 167 | 0.120 |
Why?
|
Vagina | 1 | 2014 | 47 | 0.120 |
Why?
|
Aged | 4 | 2016 | 9487 | 0.120 |
Why?
|
Antigens | 1 | 2013 | 31 | 0.120 |
Why?
|
Drug Discovery | 3 | 2018 | 30 | 0.120 |
Why?
|
Detergents | 1 | 2013 | 17 | 0.120 |
Why?
|
Chickens | 1 | 2013 | 40 | 0.120 |
Why?
|
Collagenases | 1 | 2013 | 9 | 0.110 |
Why?
|
Biomedical Engineering | 2 | 2013 | 23 | 0.110 |
Why?
|
Maf Transcription Factors, Large | 1 | 2013 | 2 | 0.110 |
Why?
|
Platelet Activating Factor | 2 | 2004 | 14 | 0.110 |
Why?
|
Laminin | 1 | 2013 | 13 | 0.110 |
Why?
|
Recombinant Proteins | 2 | 2005 | 248 | 0.110 |
Why?
|
Age Factors | 2 | 2014 | 1108 | 0.110 |
Why?
|
Integrins | 1 | 2013 | 20 | 0.110 |
Why?
|
Culture Media, Serum-Free | 1 | 2012 | 15 | 0.110 |
Why?
|
Fibrin | 1 | 2012 | 6 | 0.110 |
Why?
|
Implants, Experimental | 1 | 2012 | 12 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 45 | 0.110 |
Why?
|
Graft Survival | 2 | 2011 | 228 | 0.110 |
Why?
|
C-Peptide | 1 | 2012 | 25 | 0.110 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 42 | 0.110 |
Why?
|
Culture Media, Conditioned | 1 | 2012 | 52 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 39 | 0.110 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 180 | 0.110 |
Why?
|
Skin, Artificial | 1 | 2012 | 31 | 0.110 |
Why?
|
Larynx | 1 | 2012 | 19 | 0.110 |
Why?
|
Chondroitin Sulfates | 1 | 2012 | 22 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2012 | 30 | 0.110 |
Why?
|
Pancreatic Diseases | 1 | 2012 | 16 | 0.110 |
Why?
|
Muscle, Striated | 1 | 2012 | 5 | 0.110 |
Why?
|
Liver Failure | 1 | 2012 | 17 | 0.110 |
Why?
|
Intestinal Diseases | 1 | 2012 | 18 | 0.110 |
Why?
|
Myositis | 1 | 2011 | 10 | 0.110 |
Why?
|
Intestine, Small | 1 | 2012 | 34 | 0.110 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2012 | 75 | 0.100 |
Why?
|
Solubility | 2 | 2020 | 38 | 0.100 |
Why?
|
Edema | 1 | 2011 | 30 | 0.100 |
Why?
|
Transplantation Tolerance | 1 | 2011 | 14 | 0.100 |
Why?
|
Ligation | 1 | 2011 | 55 | 0.100 |
Why?
|
Odds Ratio | 1 | 2013 | 447 | 0.100 |
Why?
|
North Carolina | 1 | 2016 | 1423 | 0.100 |
Why?
|
Urinary Incontinence | 1 | 2012 | 45 | 0.100 |
Why?
|
Macaca fascicularis | 1 | 2013 | 389 | 0.100 |
Why?
|
History, 20th Century | 1 | 2011 | 68 | 0.100 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2011 | 15 | 0.100 |
Why?
|
Azacitidine | 1 | 2011 | 28 | 0.100 |
Why?
|
Cell Communication | 1 | 2011 | 30 | 0.100 |
Why?
|
Urethral Stricture | 1 | 2011 | 29 | 0.100 |
Why?
|
Pregnancy | 2 | 2012 | 815 | 0.100 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2010 | 15 | 0.100 |
Why?
|
Sex Factors | 1 | 2013 | 631 | 0.100 |
Why?
|
Chondrocytes | 1 | 2011 | 71 | 0.100 |
Why?
|
Muscle Strength | 1 | 2011 | 139 | 0.100 |
Why?
|
Animals, Newborn | 1 | 2011 | 111 | 0.100 |
Why?
|
Cell Division | 4 | 2005 | 97 | 0.100 |
Why?
|
Radiation Injuries, Experimental | 1 | 2010 | 33 | 0.100 |
Why?
|
Osteopontin | 1 | 2010 | 9 | 0.100 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2011 | 71 | 0.100 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 36 | 0.090 |
Why?
|
Cell Count | 1 | 2010 | 50 | 0.090 |
Why?
|
Trachea | 1 | 2010 | 55 | 0.090 |
Why?
|
Nanotechnology | 2 | 2012 | 15 | 0.090 |
Why?
|
Rats, Nude | 1 | 2010 | 38 | 0.090 |
Why?
|
Mechanical Phenomena | 1 | 2010 | 27 | 0.090 |
Why?
|
Pancreas Transplantation | 1 | 2010 | 80 | 0.090 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2009 | 18 | 0.090 |
Why?
|
Nanostructures | 1 | 2009 | 16 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2012 | 259 | 0.090 |
Why?
|
Osteoblasts | 1 | 2009 | 46 | 0.090 |
Why?
|
Diabetes Mellitus | 1 | 2012 | 366 | 0.090 |
Why?
|
Guided Tissue Regeneration | 2 | 2008 | 36 | 0.090 |
Why?
|
NIH 3T3 Cells | 2 | 2007 | 43 | 0.090 |
Why?
|
Muscle Cells | 1 | 2009 | 7 | 0.090 |
Why?
|
Inflammation | 1 | 2012 | 507 | 0.090 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2011 | 190 | 0.090 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 320 | 0.080 |
Why?
|
Parthenogenesis | 1 | 2008 | 7 | 0.080 |
Why?
|
Multipotent Stem Cells | 1 | 2008 | 15 | 0.080 |
Why?
|
Oocytes | 1 | 2008 | 21 | 0.080 |
Why?
|
DNA Primers | 3 | 2005 | 87 | 0.080 |
Why?
|
Vascular Patency | 3 | 2014 | 66 | 0.080 |
Why?
|
Neuropilins | 1 | 2008 | 1 | 0.080 |
Why?
|
Genetic Engineering | 1 | 2008 | 19 | 0.080 |
Why?
|
Adolescent | 6 | 2014 | 3254 | 0.080 |
Why?
|
Penis | 1 | 2008 | 33 | 0.080 |
Why?
|
Nerve Regeneration | 1 | 2008 | 40 | 0.080 |
Why?
|
Base Sequence | 3 | 2005 | 240 | 0.080 |
Why?
|
Immunochemistry | 1 | 2007 | 8 | 0.080 |
Why?
|
Blood Cells | 1 | 2007 | 9 | 0.080 |
Why?
|
Thrombospondins | 1 | 2007 | 7 | 0.080 |
Why?
|
Urine | 1 | 2008 | 59 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2008 | 48 | 0.080 |
Why?
|
Aspartate Aminotransferases | 1 | 2007 | 28 | 0.080 |
Why?
|
Microtubules | 1 | 2007 | 17 | 0.080 |
Why?
|
Alanine Transaminase | 1 | 2007 | 44 | 0.080 |
Why?
|
Prostatectomy | 1 | 2008 | 79 | 0.080 |
Why?
|
Chondrogenesis | 1 | 2007 | 18 | 0.080 |
Why?
|
Prostate | 1 | 2007 | 68 | 0.080 |
Why?
|
Pulsatile Flow | 3 | 2012 | 25 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2007 | 18 | 0.070 |
Why?
|
Prosthesis Design | 3 | 2012 | 87 | 0.070 |
Why?
|
Transforming Growth Factors | 1 | 2006 | 3 | 0.070 |
Why?
|
Microscopy, Electron, Scanning | 3 | 2015 | 92 | 0.070 |
Why?
|
Hepatocyte Growth Factor | 1 | 2006 | 5 | 0.070 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2006 | 13 | 0.070 |
Why?
|
Heart Failure | 1 | 2012 | 568 | 0.070 |
Why?
|
Macaca mulatta | 1 | 2007 | 322 | 0.070 |
Why?
|
Sheep | 3 | 2012 | 221 | 0.070 |
Why?
|
Urinary Bladder Diseases | 1 | 2006 | 18 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2007 | 109 | 0.070 |
Why?
|
Hemangioma | 1 | 2006 | 18 | 0.070 |
Why?
|
Adipogenesis | 1 | 2006 | 26 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2003 | 97 | 0.070 |
Why?
|
Glycolates | 1 | 2005 | 5 | 0.070 |
Why?
|
Elastin | 1 | 2005 | 14 | 0.070 |
Why?
|
Polyethylene Glycols | 2 | 2016 | 65 | 0.070 |
Why?
|
Gene Dosage | 1 | 2005 | 34 | 0.070 |
Why?
|
Genetic Enhancement | 1 | 2005 | 5 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2005 | 28 | 0.070 |
Why?
|
Protein Engineering | 1 | 2005 | 17 | 0.070 |
Why?
|
Mice, Inbred C3H | 1 | 2005 | 23 | 0.070 |
Why?
|
Intracellular Space | 1 | 2005 | 16 | 0.070 |
Why?
|
Gene Transfer Techniques | 2 | 2002 | 69 | 0.070 |
Why?
|
Particle Size | 1 | 2005 | 42 | 0.070 |
Why?
|
Neoplasms, Experimental | 1 | 2005 | 27 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2007 | 192 | 0.070 |
Why?
|
Quinazolines | 1 | 2005 | 31 | 0.070 |
Why?
|
Green Fluorescent Proteins | 2 | 2017 | 71 | 0.070 |
Why?
|
Child | 5 | 2011 | 2219 | 0.060 |
Why?
|
Protein Binding | 2 | 2002 | 199 | 0.060 |
Why?
|
Fibrosis | 2 | 2017 | 102 | 0.060 |
Why?
|
P-Selectin | 1 | 2004 | 10 | 0.060 |
Why?
|
Piperidines | 1 | 2005 | 125 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 2 | 2017 | 82 | 0.060 |
Why?
|
U937 Cells | 1 | 2002 | 8 | 0.060 |
Why?
|
Leukemia, Experimental | 1 | 2002 | 3 | 0.060 |
Why?
|
Regional Blood Flow | 2 | 2013 | 82 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2002 | 23 | 0.060 |
Why?
|
RNA, Neoplasm | 1 | 2002 | 20 | 0.060 |
Why?
|
Polyglycolic Acid | 3 | 2011 | 32 | 0.060 |
Why?
|
Histocompatibility | 1 | 2002 | 5 | 0.050 |
Why?
|
Nuclear Transfer Techniques | 1 | 2002 | 9 | 0.050 |
Why?
|
Optics and Photonics | 2 | 2012 | 7 | 0.050 |
Why?
|
Cloning, Organism | 1 | 2002 | 12 | 0.050 |
Why?
|
Clone Cells | 3 | 2007 | 36 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2002 | 72 | 0.050 |
Why?
|
Microcirculation | 2 | 2012 | 61 | 0.050 |
Why?
|
Affinity Labels | 1 | 2002 | 1 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 11 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2002 | 15 | 0.050 |
Why?
|
Porosity | 2 | 2012 | 36 | 0.050 |
Why?
|
Ischemia | 1 | 2002 | 92 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2002 | 38 | 0.050 |
Why?
|
Acute Disease | 1 | 2002 | 239 | 0.050 |
Why?
|
Tyrosine | 1 | 2002 | 22 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2002 | 118 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2002 | 56 | 0.050 |
Why?
|
Kinetics | 1 | 2002 | 205 | 0.050 |
Why?
|
Models, Molecular | 1 | 2002 | 178 | 0.050 |
Why?
|
Homeostasis | 1 | 2002 | 127 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2002 | 514 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2014 | 3099 | 0.050 |
Why?
|
Disease Progression | 1 | 2002 | 572 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2012 | 263 | 0.040 |
Why?
|
Myosin Heavy Chains | 2 | 2011 | 86 | 0.040 |
Why?
|
Cystoscopy | 2 | 2011 | 26 | 0.040 |
Why?
|
Immunosuppressive Agents | 2 | 2010 | 167 | 0.040 |
Why?
|
Electric Stimulation | 2 | 2008 | 102 | 0.040 |
Why?
|
Transplantation | 1 | 2018 | 12 | 0.040 |
Why?
|
Urothelium | 2 | 2008 | 51 | 0.040 |
Why?
|
Isometric Contraction | 1 | 2017 | 21 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2017 | 42 | 0.040 |
Why?
|
Microfluidics | 1 | 2017 | 15 | 0.040 |
Why?
|
Keratinocytes | 1 | 2017 | 26 | 0.040 |
Why?
|
Hepatectomy | 1 | 2017 | 66 | 0.040 |
Why?
|
Administration, Intravesical | 2 | 2010 | 22 | 0.040 |
Why?
|
Organ Size | 1 | 2017 | 196 | 0.040 |
Why?
|
Body Burden | 1 | 2016 | 6 | 0.040 |
Why?
|
Fibroblasts | 1 | 2017 | 103 | 0.040 |
Why?
|
Astronauts | 1 | 2016 | 7 | 0.040 |
Why?
|
Colon | 1 | 2017 | 56 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2017 | 106 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2016 | 25 | 0.040 |
Why?
|
Radiation Dosage | 1 | 2016 | 72 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2017 | 102 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2007 | 24 | 0.040 |
Why?
|
Stage-Specific Embryonic Antigens | 1 | 2016 | 1 | 0.040 |
Why?
|
Genome, Human | 1 | 2016 | 129 | 0.040 |
Why?
|
Tubulin | 1 | 2016 | 10 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2016 | 37 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2016 | 22 | 0.030 |
Why?
|
Body Weight | 1 | 2017 | 290 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2015 | 16 | 0.030 |
Why?
|
Corrosion Casting | 1 | 2015 | 9 | 0.030 |
Why?
|
Tissue Survival | 1 | 2015 | 12 | 0.030 |
Why?
|
Solutions | 1 | 2015 | 26 | 0.030 |
Why?
|
Transplantation, Autologous | 2 | 2008 | 78 | 0.030 |
Why?
|
Lasers | 1 | 2015 | 19 | 0.030 |
Why?
|
Urea | 1 | 2015 | 33 | 0.030 |
Why?
|
Albumins | 1 | 2015 | 38 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 28 | 0.030 |
Why?
|
Feedback | 1 | 2015 | 33 | 0.030 |
Why?
|
Glycosaminoglycans | 2 | 2007 | 20 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2014 | 35 | 0.030 |
Why?
|
Metaplasia | 1 | 2014 | 20 | 0.030 |
Why?
|
Forecasting | 1 | 2014 | 133 | 0.030 |
Why?
|
Quartz | 1 | 2013 | 1 | 0.030 |
Why?
|
Waiting Lists | 1 | 2013 | 30 | 0.030 |
Why?
|
Biopsy | 1 | 2014 | 241 | 0.030 |
Why?
|
Ultrasonography, Doppler, Pulsed | 1 | 2012 | 5 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 18 | 0.030 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2012 | 17 | 0.030 |
Why?
|
Viscosity | 1 | 2012 | 21 | 0.030 |
Why?
|
Graft Occlusion, Vascular | 1 | 2012 | 21 | 0.030 |
Why?
|
Elasticity | 1 | 2012 | 34 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 42 | 0.030 |
Why?
|
Punctures | 1 | 2012 | 32 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2012 | 30 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 41 | 0.030 |
Why?
|
Needles | 1 | 2012 | 28 | 0.030 |
Why?
|
Silicon Dioxide | 1 | 2012 | 8 | 0.030 |
Why?
|
Photons | 1 | 2012 | 7 | 0.030 |
Why?
|
Electrons | 1 | 2012 | 11 | 0.030 |
Why?
|
Injections | 1 | 2012 | 61 | 0.030 |
Why?
|
Microspheres | 1 | 2012 | 37 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2012 | 43 | 0.030 |
Why?
|
Light | 1 | 2012 | 25 | 0.030 |
Why?
|
Infant | 2 | 2006 | 969 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 62 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2012 | 56 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2012 | 80 | 0.030 |
Why?
|
Child, Preschool | 2 | 2006 | 1167 | 0.030 |
Why?
|
Models, Statistical | 1 | 2012 | 163 | 0.020 |
Why?
|
Mexico | 1 | 2011 | 63 | 0.020 |
Why?
|
Actins | 1 | 2011 | 52 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2011 | 50 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 2010 | 17 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2011 | 40 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2011 | 37 | 0.020 |
Why?
|
Femoral Artery | 1 | 2011 | 44 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 113 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2011 | 62 | 0.020 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2010 | 5 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2010 | 28 | 0.020 |
Why?
|
Crystallization | 1 | 2009 | 16 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 37 | 0.020 |
Why?
|
Cohort Studies | 1 | 2014 | 1687 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2010 | 454 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 2009 | 5 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 37 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 44 | 0.020 |
Why?
|
MyoD Protein | 1 | 2008 | 9 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 65 | 0.020 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2008 | 18 | 0.020 |
Why?
|
Sampling Studies | 1 | 2008 | 40 | 0.020 |
Why?
|
Femoral Nerve | 1 | 2008 | 6 | 0.020 |
Why?
|
Brain | 1 | 2016 | 930 | 0.020 |
Why?
|
Neuropilin-2 | 1 | 2008 | 1 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 7 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2008 | 10 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 224 | 0.020 |
Why?
|
Integrin alpha6 | 1 | 2007 | 2 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2007 | 17 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2007 | 20 | 0.020 |
Why?
|
Blood Pressure | 1 | 2012 | 804 | 0.020 |
Why?
|
Quality of Life | 1 | 2013 | 816 | 0.020 |
Why?
|
Collagen Type II | 1 | 2007 | 8 | 0.020 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2007 | 4 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2007 | 21 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 2402 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 27 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 871 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2007 | 71 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2007 | 24 | 0.020 |
Why?
|
Cartilage | 1 | 2007 | 30 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 66 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 532 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 273 | 0.020 |
Why?
|
Meningomyelocele | 1 | 2006 | 9 | 0.020 |
Why?
|
X Chromosome Inactivation | 1 | 2006 | 5 | 0.020 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2006 | 6 | 0.020 |
Why?
|
Granuloma, Pyogenic | 1 | 2006 | 4 | 0.020 |
Why?
|
Postoperative Period | 1 | 2006 | 91 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 44 | 0.020 |
Why?
|
Shear Strength | 1 | 2005 | 8 | 0.020 |
Why?
|
Tensile Strength | 1 | 2005 | 52 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2011 | 2108 | 0.020 |
Why?
|
Circumcision, Male | 1 | 2005 | 4 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2005 | 4 | 0.020 |
Why?
|
Lactic Acid | 1 | 2005 | 52 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 43 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2006 | 90 | 0.020 |
Why?
|
Genetic Markers | 1 | 2005 | 122 | 0.020 |
Why?
|
Adipocytes | 1 | 2005 | 79 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 394 | 0.020 |
Why?
|
Protein Transport | 1 | 2004 | 74 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2006 | 598 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2006 | 206 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 102 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2008 | 670 | 0.010 |
Why?
|
Lac Operon | 1 | 2002 | 5 | 0.010 |
Why?
|
Hydrochloric Acid | 1 | 2002 | 5 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2002 | 13 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2002 | 84 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2002 | 3 | 0.010 |
Why?
|
Escherichia coli | 1 | 2002 | 82 | 0.010 |
Why?
|